omeprazole has been researched along with Gastroenteritis in 12 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Gastroenteritis: INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.
Excerpt | Relevance | Reference |
---|---|---|
"A prolonged GA inhibitor-induced hypochlorhydria has been suggested as a risk factor for severe gastrointestinal infections." | 1.33 | Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. ( Canani, RB; Cirillo, P; Guarino, A; Malamisura, B; Manguso, F; Morelli, L; Passariello, A; Roggero, P; Romano, C; Terrin, G, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wei, L | 1 |
Ratnayake, L | 1 |
Phillips, G | 1 |
McGuigan, CC | 1 |
Morant, SV | 1 |
Flynn, RW | 1 |
Mackenzie, IS | 1 |
MacDonald, TM | 1 |
Reimer, C | 1 |
Bytzer, P | 1 |
Wilton, LV | 1 |
Key, C | 1 |
Shakir, SA | 1 |
Pohland, CJ | 1 |
Scavnicky, SA | 1 |
Lasky, SS | 1 |
Good, CB | 1 |
Kornienko, EA | 1 |
Klochko, OG | 1 |
Tiesmeier, J | 1 |
Hinner, H | 1 |
Kraus, J | 1 |
Schuppert, F | 1 |
Canani, RB | 1 |
Cirillo, P | 1 |
Roggero, P | 1 |
Romano, C | 1 |
Malamisura, B | 1 |
Terrin, G | 1 |
Passariello, A | 1 |
Manguso, F | 1 |
Morelli, L | 1 |
Guarino, A | 1 |
García Rodríguez, LA | 1 |
Ruigómez, A | 1 |
Panés, J | 1 |
Neal, KR | 1 |
Scott, HM | 1 |
Slack, RC | 1 |
Logan, RF | 1 |
Tan, AC | 1 |
den Hartog, G | 1 |
Meijer, JW | 1 |
Thies, JE | 1 |
de Vries, RA | 1 |
Mulder, CJ | 1 |
Neal, K | 1 |
Logan, R | 1 |
Wingate, DL | 1 |
3 trials available for omeprazole and Gastroenteritis
Article | Year |
---|---|
[Comparative efficacy of proton pump inhibitors in children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; | 2003 |
Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Bacterial Infections; Enzyme Inhibitors; Femal | 2007 |
No additional value of bismuth subcitrate to combination omeprazole/amoxicillin therapy in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Biopsy; Data Interpreta | 1997 |
9 other studies available for omeprazole and Gastroenteritis
Article | Year |
---|---|
Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Child; Child, Preschool; Cohort St | 2017 |
[Adverse events associated with long-term use of proton pump inhibitors].
Topics: Anti-Ulcer Agents; Bacterial Infections; Congenital Abnormalities; Dyspepsia; Fractures, Bone; Gastr | 2012 |
The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agen | 2003 |
Lansoprazole overutilization: methods for step-down therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Costs; Drug Utilization Review; Enz | 2003 |
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal U | 2004 |
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Topics: Achlorhydria; Acute Disease; Anti-Ulcer Agents; Child, Preschool; Community-Acquired Infections; Gas | 2006 |
Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Campylobacter Infections; Case-Control Studies; Gast | 1996 |
Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
Topics: Anti-Ulcer Agents; Campylobacter Infections; Gastric Acid; Gastroenteritis; Gastroesophageal Reflux; | 2001 |
Acid reduction and recurrent enteritis.
Topics: Adult; Gastroenteritis; Humans; Male; Omeprazole; Recurrence; Salmonella Infections | 1990 |